SCLX Stock Acquisition JV LLC - Jan 21, 2025 Form 4 Insider Report for Scilex Holding Co (SCLX)

Role: 10%+ Owner
Signature: /s/ Xiao Xu, Sole Manager
Stock symbol: SCLX
Transactions as of: Jan 21, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/23/2025, 07:49 PM
Previous filing: Jan 17, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SCLX	Common Stock	Other		-3.25M	-5.99%		51M	Jan 21, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transferred pursuant to the terms of an Amendment to Senior Secured Promissory Note (the "Amendment Letter") the Issuer and the Reporting Person entered into with Oramed Pharmaceuticals Inc. ("Oramed") for the extension of the maturity date of that certain senior secured promissory note previously issued by the Issuer to Oramed on September 21, 2023. Under the terms of the Amendment Letter and in consideration for such extension and to limit certain noteholders' rights to exercise certain secured creditor remedies (including recourse against the assets of the Reporting Person as a grantor under the Security Agreement (as defined in the Amendment Letter)), the Reporting Person transferred to Oramed an aggregate of 3,250,000 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person.

Content

Transferred pursuant to the terms of an Amendment to Senior Secured Promissory Note (the "Amendment Letter") the Issuer and the Reporting Person entered into with Oramed Pharmaceuticals Inc. ("Oramed") for the extension of the maturity date of that certain senior secured promissory note previously issued by the Issuer to Oramed on September 21, 2023. Under the terms of the Amendment Letter and in consideration for such extension and to limit certain noteholders' rights to exercise certain secured creditor remedies (including recourse against the assets of the Reporting Person as a grantor under the Security Agreement (as defined in the Amendment Letter)), the Reporting Person transferred to Oramed an aggregate of 3,250,000 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person.